Kathy Yi
Direttore operativo presso Affini-T Therapeutics, Inc.
Posizioni attive di Kathy Yi
Società | Posizione | Inizio | Fine |
---|---|---|---|
Sangamo Therapeutics UK Ltd.
Sangamo Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Sangamo Therapeutics UK Ltd. researches and develops transcription factors in the regulation of genes. The company was founded on April 21, 1999 and is headquartered in Cheltenham, the United Kingdom. | Direttore/Membro del Consiglio | 28/02/2017 | - |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | Direttore operativo | - | - |
Direttore Finanziario/CFO | - | 13/11/2023 |
Storia della carriera di Kathy Yi
Precedenti posizioni note di Kathy Yi
Società | Posizione | Inizio | Fine |
---|---|---|---|
THESEUS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 10/06/2021 | 14/02/2024 |
Independent Dir/Board Member | 10/06/2021 | 14/02/2024 | |
CEREVEL THERAPEUTICS HOLDINGS, INC. | Direttore Finanziario/CFO | 01/06/2019 | 20/09/2021 |
SANGAMO THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 28/02/2017 | 07/06/2019 |
Direttore Finanziario/CFO | 28/02/2017 | 07/06/2019 | |
Segretario Aziendale | - | 07/06/2019 | |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Direttore Finanziario/CFO | 01/01/2007 | 01/01/2014 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01/01/2014 | - |
Formazione di Kathy Yi
University of California, Berkeley | Undergraduate Degree |
Columbia Business School | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Regno Unito | 2 |
Posizioni
Director of Finance/CFO | 4 |
Director/Board Member | 2 |
Comptroller/Controller/Auditor | 1 |
Settori
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
SANGAMO THERAPEUTICS, INC. | Health Technology |
CEREVEL THERAPEUTICS HOLDINGS, INC. | Health Technology |
Aziende private | 5 |
---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Commercial Services |
Sangamo Therapeutics UK Ltd.
Sangamo Therapeutics UK Ltd. Miscellaneous Commercial ServicesCommercial Services Sangamo Therapeutics UK Ltd. researches and develops transcription factors in the regulation of genes. The company was founded on April 21, 1999 and is headquartered in Cheltenham, the United Kingdom. | Commercial Services |
Theseus Pharmaceuticals, Inc.
Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA. | Health Technology |
Affini-T Therapeutics, Inc.
Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Kathy Yi
- Esperienza